Xwell extends collaboration with CDC, Prevention’s traveler-based surveillance

XWELL announced that they have renewed their support for the Centers for Disease Control and Prevention’s Traveler-based Genomic Surveillance program through a new contract awarded August 12 for approximately $16 million. The innovative collaboration between CDC, XpresCheck and Concentric by Ginkgo Bioworks will continue for another year, expanding bio-surveillance capabilities across major U.S. airports. “Through the renewed investment in this initiative, we and our partners are continuing to play an important role in U.S. biosecurity through its two major goals; early detection of new SARS-CoV-2 variants and other pathogens and by filling the gaps in global bio-surveillance,” stated Ezra Ernst, Chief Executive Officer of XpresCheck. “With CDC and Concentric by Ginkgo Bioworks, we are providing public health officials with timely insights into pathogen evolution as well as peace of mind to travelers. We have learned that people are eager to protect themselves, their communities and their global neighbors, and TGS facilitates this.”